Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20260 analyst targets · 90 days
- Share price
- $704.55
- Average 1Y price target
- $992.57+40.88%
- Agreement
- Low
Analysts agreement range is spread more than 30% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall2
- DCF4
- Return on equity1
- Return on assets5
- Debt / equity1
- P/E2
- P/B1
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 8 | $974.38 |
| Last quarter | 22 | $1,103.82 |
| Last year | 37 | $1,288.41 |
| All time | 59 | $1,495.51 |
Recent rating changes
The latest 40 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 26, 2026 | Wells Fargo | downgrade | Overweight | Equal Weight |
| Oct 26, 2026 | UBS | maintain | Neutral | Neutral |
| Oct 26, 2026 | JP Morgan | maintain | Neutral | Neutral |
| Oct 26, 2026 | BMO Capital | maintain | Outperform | Outperform |
| Oct 19, 2026 | Mizuho | maintain | Outperform | Outperform |
| Oct 16, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Oct 13, 2026 | Raymond James | maintain | Outperform | Outperform |
| Oct 13, 2026 | Needham | maintain | Buy | Buy |
| Oct 5, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| Oct 2, 2026 | Barclays | maintain | Overweight | Overweight |
| Oct 2, 2026 | Baird | maintain | Outperform | Outperform |
| Sep 30, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| Sep 30, 2026 | B of A Securities | downgrade | Buy | Neutral |
| Sep 30, 2026 | BMO Capital | maintain | Outperform | Outperform |
| Sep 30, 2026 | Barclays | maintain | Overweight | Overweight |
| Sep 22, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| Aug 12, 2026 | UBS | maintain | Neutral | Neutral |
| Aug 10, 2026 | Barclays | maintain | Overweight | Overweight |
| Aug 3, 2026 | Wolfe Research | downgrade | Outperform | Peer Perform |
| Jul 30, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| Jul 30, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Jul 30, 2026 | Needham | maintain | Buy | Buy |
| Jul 2, 2026 | UBS | maintain | Neutral | Neutral |
| Jun 16, 2026 | UBS | maintain | Neutral | Neutral |
| Jun 9, 2026 | Needham | maintain | Buy | Buy |
| May 19, 2026 | B of A Securities | maintain | Buy | Buy |
| May 4, 2026 | Jefferies | maintain | Buy | Buy |
| Apr 30, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| Apr 30, 2026 | JP Morgan | maintain | Neutral | Neutral |
| Apr 29, 2026 | Needham | maintain | Buy | Buy |
| Apr 23, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| Apr 23, 2026 | UBS | maintain | Neutral | Neutral |
| Apr 10, 2026 | Barclays | maintain | Overweight | Overweight |
| Apr 2, 2026 | Goldman Sachs | maintain | Buy | Buy |
| Mar 24, 2026 | JP Morgan | maintain | Neutral | Neutral |
| Mar 24, 2026 | Baird | maintain | Outperform | Outperform |
| Mar 18, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| Mar 11, 2026 | UBS | maintain | Neutral | Neutral |
| Feb 3, 2026 | Goldman Sachs | maintain | Buy | Buy |
| Jan 29, 2026 | Needham | maintain | Buy | Buy |